Franklin M Berger Essa Pharma Inc. (EPIX) insider trading activity

Franklin M Berger is Director of ESSA Pharma Inc.. Currently has a direct ownership of 0 shares of EPIX, which is worth approximately $0. The most recent transaction as insider was on Oct 09, 2025, when has been sold 784,404 shares (Common Shares) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 0

100.0% 3M change

100.0% 12M change

Total Value Held $0

FRANKLIN M BERGER Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Oct 09 2025	SELL Sale (or disposition) back to the issuer	-	784,404 Reduced 100.0%	0 Common Shares
Nov 21 2023	BUY Open market or private purchase	$133,274 $5.73 p/Share	23,259 Added 2.88%	784,404 Common Shares
Nov 03 2023	BUY Open market or private purchase	$98,661 $5.99 p/Share	16,471 Added 2.12%	760,875 Common Stock
Nov 02 2023	BUY Open market or private purchase	$321,000 $5.35 p/Share	60,000 Added 7.46%	744,404 Common Stock
Dec 21 2022	SELL Open market or private sale	$174,779 $2.42 p/Share	72,223 Reduced 9.55%	684,404 Common Shares
Dec 20 2022	SELL Open market or private sale	$110,351 $2.53 p/Share	43,617 Reduced 5.45%	756,627 Common Shares
Dec 16 2022	SELL Open market or private sale	$133,500 $2.67 p/Share	50,000 Reduced 5.88%	800,244 Common Shares

Dec 15 2022	SELL Open market or private sale	$236,160 $2.88 p/Share	82,000 Reduced 8.8%	850,244 Common Shares
Dec 14 2022	SELL Open market or private sale	$75,000 $3.0 p/Share	25,000 Reduced 2.61%	932,244 Common Shares
Feb 22 2021	BUY Open market or private purchase	$1,539,000 $27.0 p/Share	57,000 Added 5.62%	957,244 Common Shares
Dec 03 2020	BUY Exercise of conversion of derivative security	$166,296 $3.94 p/Share	42,207 Added 4.48%	900,244 Common Shares

Also insider at

AVIR

Atea Pharmaceuticals, Inc. Healthcare

FPRX

FIVE PRIME THERAPEUTICS, INC.

Director

RAIN

Rain Therapeutics Inc. Healthcare

Director

BCEL

Atreca, Inc. Healthcare

Director

KZR

Kezar Life Sciences, Inc. Healthcare

FMB